HealthStream, Inc. is a software-as-a-service provider offering workforce solutions for healthcare organizations and professionals. The company provides a single platform strategy built on its proprietary hStream technology platform, which integrates applications for governance, risk, and compliance (GRC), learning, credentialing, and staff scheduling. Key products include the Competency Suite for AI-driven clinical competency development, nurse and staff scheduling tools, and provider data management solutions for credentialing and privileging. HealthStream serves hospitals, post-acute care facilities, health and human services organizations, and educational institutions, as well as healthcare professionals and students. The company also offers continuing education content, including BLS, ALS, and PALS certification training, and medical product training for pharmaceutical and medical device companies. Incorporated in 1990, HealthStream began providing SaaS-based workforce solutions in 1999 and launched the hStream platform in 2018. Since January 2023, the company operates as a single reportable segment.

Summarised from the company's own disclosures, fiscal year ended Feb 2026

Industry Software - Application Homepage healthstream.com
Sector Technology IR page webflow.healthstream.com/contact/investor-relations
Tags
healthcare workforce management, governance risk and compliance, staff scheduling, medical credentialing, continuing education, clinical competency assessment, provider data management, nursing education, ai-driven learning, saas platform, hStream, Competency Suite, hStream for Credentialing, hStream Content Marketplace, hStream Developer Portal, hStream AI
Press page —

Metrics

Valuation  
Market cap $ 955.271M
Market cap (USD) $ 955.271M
P/E 44.58
PEG 2.99
P/BV 2.38
P/S 2.91
P/OCF 13.43
P/FCF 13.85
Dividend yield 0.44%
Turnover / mcap —
Returns  
ROE 5.1%
ROI 5.5%
ROIC 4.8%
Profit margin 6.0%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) 14.9%
Quality  
Profitable Yes
Margin expanding No
Buying back stock Yes
Diluting (TTM) Yes
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 23
Quality score 5.6%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000 FY 1999
Revenue 304.064M 291.646M 279.063M 266.826M 256.712M 244.826M 254.112M 231.616M 247.662M 225.974M 209.002M 170.69M 132.274M 103.732M 82.066M 65.754M 57.398M 51.6M 43.949M 31.783M 27.359M 20.057M 18.195M 15.79M 13.503M 9.652M 2.568M
Net profit 18.342M 20.007M 15.213M 12.091M 5.845M 14.091M 15.77M 32.217M 10.004M 3.755M 8.621M 10.394M 8.418M 7.645M 6.944M 4.154M 13.972M 2.855M 4.087M 2.5M 1.913M -1.048M -3.412M -16.641M -19.576M -20.285M -4.456M
Free cash flow 59.634M 56.259M 61.77M 49.42M 38.968M 33.886M 43.66M 36.08M 40.695M 19.149M 26.823M 29.712M 21.839M 18.198M 15.64M 13.494M 9.782M 4.904M 5.841M 2.597M 4.421M -1.245M -1.779M -6.449M -11.29M -17.669M -3.898M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000 FY 1999
Share price 23.07 31.8 27.03 24.84 26.36 21.84 27.2 24.15 23.16 25.05 22 29.48 32.65 24.32 15.44 4.94 4.5 2.46 3.22 3.58 — — — — — — —
Price performance 12m -0.27 0.18 0.09 -0.06 0.21 -0.2 0.13 0.04 -0.08 0.14 -0.25 -0.1 0.34 0.58 2.13 0.1 0.83 -0.24 -0.1 — — — — — — — —

Filed figures

Figure Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) 44.8M 40.8M 38.1M 27.7M 40.7M 30.3M 36.7M 34.3M 30.2M 32.2M
↳ YoY growth +23.3% -8.8% -6.7% -27.5% +47.3% -25.6% +21.2% -6.5% -12.1% +6.5%
↳ 5y CAGR +22.8% +21.6% +8.5% -3.6% +2.3% -7.5% -2.1% -2.1% +1.8% -4.6%
Lease liabilities (USD) — — 6.4M 33.5M 31.9M 26.2M 23.3M 20.2M 20.2M 17.6M
Cash and deposits (USD) 49.6M 84.8M 134M 132M 36.6M 46.9M 46M 40.3M 59.5M 36.2M
Intangible assets (USD) 78.4M 68.8M 59.4M 60.1M 101M 89.2M 81.6M 68M 55.5M 64.9M
Right-of-use assets (USD) — — 4.8M 29.6M 28.1M 25.2M 22.8M 20.1M 17.5M 15.3M
Cash flow detail
Operating cash flow (USD) 24.2M 46.7M 43.2M 65.7M 35.9M 42.4M 51.2M 64M 57.7M 63.3M
Purchases of property, plant and equipment (USD) -5.09M -6.02M -7.17M -22M -1.99M -3.42M -1.77M -2.2M -1.4M -3.69M
Purchases of intangible assets (USD) -9.72M -11.9M -11.3M -14.5M -16.8M -21.9M -23.3M -25.8M -26.7M -28.5M
Change in receivables (cash effect) (USD) -6.08M 1.13M -4.05M 11.6M -2.99M 10.3M -7.77M 3.24M 537,000 -3.98M
Change in payables (cash effect) (USD) -1.32M 2.28M 2.01M 1.1M 1.12M -4.33M 3.74M 4.83M -5.03M 1.42M
Dividends paid (cash effect) (USD) — — -32.4M -58,000 -40,000 -19,000 0.00 -3.06M -3.4M -3.73M
Share buybacks (cash effect) (USD) — — — 0.00 -20M -5.01M -23.1M -8.93M 0.00 -30M
Interest paid (cash effect) (USD) -76,000 -101,000 -117,000 -101,000 -96,000 -132,000 -99,000 -132,000 -101,000 -101,000
Income taxes paid (cash effect) (USD) -2.5M -638,000 -16.5M -630,000 -877,000 92,000 -718,000 -2.61M -8.7M -1.77M
Share-based compensation (USD) 1.97M 1.85M 1.78M 4.24M 2.22M 5.3M 3.55M 4.15M 4.47M 8.15M
Operating cash flow before change in receivables (USD) 30.3M 45.6M 47.3M 54.1M 38.9M 32M 59M 60.7M 57.1M 67.3M
Free cash flow (OCF - PPE - intangibles) (USD) 9.43M 28.8M 24.8M 29.1M 17.1M 17M 26.1M 36M 29.5M 31.2M
Income detail
Research and development expense (USD) 28.9M 27.9M 25.7M 29.1M 32.3M 41.7M 44.3M 45.5M 48.9M 51M
↳ 5y CAGR +31.1% +26.5% +17.0% +12.1% +5.9% +7.6% +9.7% +12.1% +10.9% +9.6%
Total comprehensive income (USD) 3.77M 10M 32.2M 15.8M 14.1M 5.95M 11M 15.5M 18.6M 19M
Comprehensive income to owners (USD) 3.77M 10M 32.2M 15.8M 14.1M 5.95M 11M 15.5M 18.6M 19M
Provision for credit losses (USD) 640,000 1.81M 1.03M 211,000 274,000 723,000 385,000 1.02M 2.6M 1.01M
Credit cost ratio (credit losses / average receivables) (%) 1.6% 4.2% 2.6% 0.6% 0.8% 2.0% 1.1% 2.9% 8.0% 3.2%
Reported Feb 27, 2017 Feb 26, 2018 Apr 29, 2019 Feb 28, 2022 Feb 26, 2021 Feb 28, 2022 Feb 28, 2023 Feb 26, 2024 Feb 28, 2025 Feb 27, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

HealthStream Announces Third Quarter 2026 Results | Bull 4 Bear 2 Results

Nov 02, 2026

Download PDF

NASHVILLE, Tenn.--(BUSINESS WIRE)--Nov. 2, 2026-- HealthStream, Inc. (the "Company") (Nasdaq: HSTM), a leading healthcare technology platform company for clinical workforce solutions, today announced results for the third quarter ended September 30, 2026.

Third Quarter 2026

  • Revenues of $83.3 million, up 8.9% from $76.5 million in the third quarter of 2025

  • Operating income of $6.6 million, down 13.0% from $7.6 million in the third quarter of 2025

  • Net income of $5.4 million, down 11.7% from $6.1 million in the third quarter of 2025

  • Earnings per share (EPS) of $0.18 per share (diluted), down from $0.20 per share (diluted) in the third quarter of 2025

  • Adjusted EBITDA1 of $19.3 million, up 1.0% from $19.1 million in the third quarter of 2025

  • Approximately $40 million of cash proceeds received through a private placement of HealthStream common stock

  • Board of Directors declared a quarterly cash dividend of $0.035 per share, payable on November 27, 2026 to holders of record on November 16, 2026

| 1 Adjusted EBITDA is a non-GAAP financial measure. A reconciliation of adjusted EBITDA to net income and disclosure regarding why we believe adjusted EBITDA provides useful information to investors is included later in this release. |

Financial Results:

Third Quarter 2026 Compared to Third Quarter 2025

Revenues for the third quarter of 2026 increased by $6.8 million, or 8.9%, to $83.3 million, compared to $76.5 million for the third quarter of 2025. Subscription revenues increased by $6.2 million, or 8.0%, and professional services revenues increased by $0.7 million compared to the third quarter of 2025. Compared to the third quarter of 2025, revenue growth for the third quarter of 2026 was positively impacted by $3.2 million from our acquisitions of Virsys12 and MissionCare Collective completed during the fourth quarter of 2025 and $3.6 million from growth across our existing portfolio of solutions.

Operating income was $6.6 million for the third quarter of 2026, down 13.0% from $7.6 million in the third quarter of 2025. The decline in operating income was primarily attributable to higher operating expenses to support investments in several areas of the business, primarily in our platform and enterprise applications, including personnel costs, third-party software expenses, cloud hosting, and amortization expense from our fourth quarter 2025 acquisitions. In addition, operating income was impacted by expense of approximately $250,000 incurred during the third quarter of 2026 related to the cybersecurity incident disclosed by us on July 29, 2026, after giving effect to related insurance recoveries.

Net income was $5.4 million in the third quarter of 2026, down 11.7% from $6.1 million in the third quarter of 2025, and EPS was $0.18 per share (diluted) in the third quarter of 2026, down from $0.20 per share (diluted) in the third quarter of 2025.

Adjusted EBITDA was $19.3 million for the third quarter of 2026, up 1.0% from $19.1 million in the third quarter of 2025.

At September 30, 2026, the Company had cash, cash equivalents, and marketable securities of $115.2 million. The Company does not have any outstanding indebtedness of borrowed money. Capital expenditures incurred during the third quarter of 2026 were $7.5 million.

Year-to-Date 2026 Compared to Year-to-Date 2025

For the nine months ended September 30, 2026, revenues were $248.2 million, an increase of 10.6% over revenues of $224.4 million for the first nine months of 2025. Operating income for the first nine months of 2026 increased by 25.7% to $22.4 million, compared to $17.8 million for the first nine months of 2025. The increase in operating income was primarily attributable to higher revenues partially offset by higher expenses to support investments in several areas of the business, primarily in our platform and enterprise applications, resulting in higher labor costs, as well as higher third-party software, commissions expense, amortization expense from our fourth quarter 2025 acquisitions, royalties expense, and cloud hosting. Net income for the first nine months of 2026 increased by 13.6% to $18.0 million, compared to $15.8 million for the first nine months of 2025. Earnings per share were $0.61 per share (diluted) for the first nine months of 2026, compared to $0.52 per share (diluted) for the first nine months of 2025. Adjusted EBITDA increased by 13.4% to $60.0 million for the first nine months of 2026, compared to $52.9 million for the first nine months of 2025.

Other Business Updates

On March 13, 2026, the Company announced a new share repurchase program approved by the Board of Directors under which the Company was authorized to repurchase up to $10.0 million of its outstanding shares of common stock. This share repurchase program expired on September 12, 2026 in accordance with its terms. During the three months ended September 30, 2026, the Company did not repurchase any shares of common stock under this program.

During the first nine months of 2026, the Company repurchased 432,476 shares of common stock under previously authorized share repurchase programs at an aggregate fair value of $9.3 million, reflecting an average purchase of $21.50 per share (excluding the cost of broker commissions and the 1% share repurchase excise tax imposed by the Inflation Reduction Act of 2022).

On September 14, 2026, the Company issued 1,355,932 shares of its common stock to WJRJJ Ventures, LLC in a private placement for an aggregate cash purchase price of approximately $40.0 million, reflecting a price of $29.50 per share. The Company intends to use the net proceeds received from the issuance of these shares for general corporate purposes, including continued investment in its solutions, working capital, potential acquisitions, and other strategic initiatives.

On November 2, 2026, the Board of Directors approved a quarterly cash dividend under the Company's dividend policy of $0.035 per share, payable on November 27, 2026 to holders of record on November 16, 2026.

Financial Outlook for 2026

The Company is updating its guidance for 2026 for the measures set forth below.

| | | Full Year 2026 Guidance |

| | | | Low | | | | | High | | |

| Revenue1 | | $ | 331.0 | | - | | $ | 333.0 | | million |

| | | | | | | | | | | |

| Net Income2 | | $ | 21.8 | | - | | $ | 22.4 | | million |

| | | | | | | | | | | |

| Adjusted EBITDA3 | | $ | 77.0 | | - | | $ | 78.0 | | million |

| | | | | | | | | | | |

| Capital Expenditures | | $ | 31.0 | | - | | $ | 34.0 | | million |

| 1 Previous expected Revenue guidance range was $327.0 to $332.0 million. |

| 2 Previous expected Net Income guidance range was $19.5 to $22.2 million. |

| 3 Previous expected Adjusted EBITDA guidance range was $74.0 to $78.0 million. Adjusted EBITDA is a non-GAAP financial measure. A reconciliation of projected adjusted EBITDA to projected net income (the most comparable GAAP measure) is included later in this release. |

The Company’s guidance for 2026, as set forth above, reflects the Company’s assumptions regarding, among other things, expectations for new sales and renewals, and assumes that general economic conditions do not deteriorate. This guidance does not include the impact of any future acquisitions or dispositions that we may complete during 2026, gains or losses from changes in the fair value of non-marketable equity investments or contingent consideration, or impairment of long-lived assets.

Robert A. Frist, Jr., Chief Executive Officer, HealthStream, said, “Nine months into 2026, HealthStream has grown revenues 10.6%, operating income 25.7%, and adjusted EBITDA 13.4% compared to the same period last year. Our third quarter continued that progress, with revenues up 8.9% to $83.3 million, and we are raising our full-year guidance.”

CEO Frist continued, “The clinical healthcare workforce continues to grow, and healthcare organizations need better ways to find, develop, credential, schedule, onboard, and retain these professionals. Our hStream platform brings together verified healthcare professionals and students, healthcare organizations, and industry partners in one powerful ecosystem. The clinical workforce is the heartbeat of American healthcare, and HealthStream is building the infrastructure it runs on.”

A conference call with Robert A. Frist, Jr., Chief Executive Officer, Scott A. Roberts, Chief Financial Officer and Senior Vice President, and Mollie Condra, Head, Investor Relations & Corporate Communications, will be held on Tuesday, November 3, 2026, at 9:00 a.m. (ET). Participants may access the conference call live via webcast using this link: https://edge.media-server.com/mmc/p/rrasd788. To participate via telephone, please register in advance using this link: https://register-conf.media-server.com/register/BI02855f88e0364e1883356079b21aef8e. A replay of the conference call and webcast will be archived on the Company’s website in the Investor Relations section under “Events & Presentations.”

Use of Non-GAAP Financial Measures

This press release presents adjusted EBITDA, a non-GAAP financial measure used by management in analyzing the Company’s financial results and ongoing operational performance. In order to better assess the Company’s financial results, management believes that net income before interest, income taxes, stock-based compensation, depreciation and amortization, impairments of long-lived assets, changes in fair value of contingent consideration, changes in fair value of, including gains (losses) on the sale of, non-marketable equity investments, and expense related to the cybersecurity incident disclosed by us on July 29, 2026 (the “Cybersecurity Incident”), after giving effect to related insurance recoveries (“adjusted EBITDA”), is a useful measure for evaluating the operating performance of the Company because adjusted EBITDA reflects net income adjusted for certain GAAP accounting, non-cash, and/or non-operating items which may not, in any such case, fully reflect the underlying operating performance of our business. We believe that adjusted EBITDA is useful to investors to assess the Company’s ongoing operating performance and to compare the Company’s operating performance between periods. In addition, certain short-term cash incentive bonuses and performance-based equity awards are based on the achievement of adjusted EBITDA (as defined in applicable bonus and equity grant documentation) targets.

The Company has included an adjustment in the definition of adjusted EBITDA for the expense related to the Cybersecurity Incident incurred during the third quarter of 2026, after giving effect to related insurance recoveries, because the Company believes that this expense amount may not be reflective of the underlying operational performance of the Company’s business and that including this adjustment is consistent with the intended purpose of adjusted EBITDA of reflecting the underlying operating performance of the Company’s business and comparing the Company’s operational performance between periods.

Adjusted EBITDA is a non-GAAP financial measure and should not be considered as a measure of financial performance under GAAP. Because adjusted EBITDA is not a measurement determined in accordance with GAAP, adjusted EBITDA is susceptible to varying calculations. Accordingly, adjusted EBITDA, as presented, may not be comparable to other similarly titled measures of other companies and has limitations as an analytical tool.

Adjusted EBITDA should not be considered a substitute for, or superior to, measures of financial performance, which are prepared in accordance with GAAP. Investors are encouraged to review the reconciliations of adjusted EBITDA to net income (the most comparable GAAP measure), which is set forth below in this release.

About****HealthStream

HealthStream (Nasdaq: HSTM) is the healthcare industry’s largest ecosystem of platform-delivered clinical workforce solutions that empowers healthcare professionals to do what they do best: deliver excellence in patient care. For more information about HealthStream, visit www.healthstream.com or call 615-301-3100.

| HEALTHSTREAM, INC. Condensed Consolidated Statements of Income (In thousands, except per share data) (Unaudited) |

| | | Three Months Ended | | | Nine Months Ended | |

| | | September 30, 2026 | | | September 30, 2025 | | | September 30, 2026 | | | September 30, 2025 | |

| Revenues, net | | $ | 83,309 | | | $ | 76,474 | | | $ | 248,244 | | | $ | 224,355 | |

| Operating costs and expenses: | | | | | | | | | | | | | | | | |

| Cost of revenues (excluding depreciation and amortization) | | | 30,010 | | | | 26,507 | | | | 86,784 | | | | 78,357 | |

| Product development | | | 13,525 | | | | 12,107 | | | | 40,712 | | | | 36,228 | |

| Sales and marketing | | | 13,320 | | | | 12,143 | | | | 39,783 | | | | 36,101 | |

| General and administrative | | | 8,602 | | | | 7,330 | | | | 24,641 | | | | 23,396 | |

| Depreciation and amortization | | | 11,265 | | | | 10,820 | | | | 33,905 | | | | 32,441 | |

| Total operating costs and expenses | | | 76,722 | | | | 68,907 | | | | 225,825 | | | | 206,523 | |

| | | | | | | | | | | | | | | | | |

| Operating income | | | 6,587 | | | | 7,567 | | | | 22,419 | | | | 17,832 | |

| | | | | | | | | | | | | | | | | |

| Interest income | | | 510 | | | | 788 | | | | 1,399 | | | | 2,676 | |

| Other expense, net | | | (28 | ) | | | (103 | ) | | | (233 | ) | | | (141 | ) |

| | | | | | | | | | | | | | | | | |

| Income before income tax provision | | | 7,069 | | | | 8,252 | | | | 23,585 | | | | 20,367 | |

| Income tax provision | | | 1,696 | | | | 2,166 | | | | 5,634 | | | | 4,559 | |

| Net income | | $ | 5,373 | | | $ | 6,086 | | | $ | 17,951 | | | $ | 15,808 | |

| | | | | | | | | | | | | | | | | |

| Net income per share: | | | | | | | | | | | | | | | | |

| Basic | | $ | 0.18 | | | $ | 0.20 | | | $ | 0.61 | | | $ | 0.52 | |

| Diluted | | $ | 0.18 | | | $ | 0.20 | | | $ | 0.61 | | | $ | 0.52 | |

| | | | | | | | | | | | | | | | | |

| Weighted average shares of common stock outstanding: | | | | | | | | | | | | | | | | |

| Basic | | | 29,491 | | | | 29,688 | | | | 29,366 | | | | 30,151 | |

| Diluted | | | 29,656 | | | | 29,811 | | | | 29,465 | | | | 30,283 | |

| Dividends declared per share | | $ | 0.035 | | | $ | 0.031 | | | $ | 0.105 | | | $ | 0.093 | |

| HEALTHSTREAM, INC. Condensed Consolidated Balance Sheets (In thousands) (Unaudited) |

| | | September 30**,** | | | December 31**,** | |

| | | 2026 | | | 2025 | |

| ASSETS | | | | | | | | |

| Current assets: | | | | | | | | |

| Cash and cash equivalents | | $ | 58,964 | | | $ | 36,161 | |

| Marketable securities | | | 56,197 | | | | 20,843 | |

| Accounts and unbilled receivables, net | | | 38,727 | | | | 38,998 | |

| Prepaid and other current assets | | | 25,470 | | | | 23,654 | |

| Total current assets | | | 179,358 | | | | 119,656 | |

| | | | | | | | | |

| Capitalized software development, net | | | 47,014 | | | | 45,581 | |

| Property and equipment, net | | | 9,659 | | | | 10,661 | |

| Operating lease right of use assets, net | | | 13,276 | | | | 15,272 | |

| Goodwill and intangible assets, net | | | 269,130 | | | | 282,448 | |

| Other assets | | | 47,414 | | | | 46,756 | |

| Total assets | | $ | 565,851 | | | $ | 520,374 | |

| | | | | | | | | |

| LIABILITIES AND SHAREHOLDERS’ EQUITY | | | | | | | | |

| Current liabilities: | | | | | | | | |

| Accounts payable, accrued, and other liabilities | | $ | 29,328 | | | $ | 35,729 | |

| Deferred revenue | | | 91,861 | | | | 88,417 | |

| Total current liabilities | | | 121,189 | | | | 124,146 | |

| Deferred tax liabilities | | | 23,449 | | | | 18,246 | |

| Deferred revenue, noncurrent | | | 1,024 | | | | 1,344 | |

| Operating lease liability, noncurrent | | | 12,777 | | | | 14,684 | |

| Other long-term liabilities | | | 5,472 | | | | 7,931 | |

| Total liabilities | | | 163,911 | | | | 166,351 | |

| | | | | | | | | |

| Shareholders’ equity: | | | | | | | | |

| Common stock | | | 265,266 | | | | 231,797 | |

| Accumulated other comprehensive loss | | | (1,794 | ) | | | (1,361 | ) |

| Retained earnings | | | 138,468 | | | | 123,587 | |

| Total shareholders’ equity | | | 401,940 | | | | 354,023 | |

| Total liabilities and shareholders' equity | | $ | 565,851 | | | $ | 520,374 | |

| HEALTHSTREAM, INC. Condensed Consolidated Statements of Cash Flows (In thousands) (Unaudited) |

| | | Nine Months Ended | |

| | | September 30**,** | | | September 30**,** | |

| | | 2026 | | | 2025 | |

| Operating activities: | | | | | | | | |

| Net income | | $ | 17,951 | | | $ | 15,808 | |

| Adjustments to reconcile net income to net cash provided by operating activities: | | | | | | | | |

| Depreciation and amortization | | | 33,905 | | | | 32,441 | |

| Stock-based compensation | | | 3,611 | | | | 2,734 | |

| Amortization of deferred commissions | | | 10,453 | | | | 9,190 | |

| Deferred income taxes | | | 5,220 | | | | 5,055 | |

| Provision for credit losses | | | 193 | | | | 568 | |

| Loss on equity method investments | | | 91 | | | | 150 | |

| Other | | | (548 | ) | | | (1,146 | ) |

| Changes in assets and liabilities: | | | | | | | | |

| Accounts and unbilled receivables | | | 49 | | | | 1,033 | |

| Prepaid and other assets | | | (9,984 | ) | | | (12,061 | ) |

| Accounts payable, accrued, and other liabilities | | | (6,047 | ) | | | (4,739 | ) |

| Deferred revenue | | | 3,064 | | | | 1,094 | |

| Net cash provided by operating activities | | | 57,958 | | | | 50,127 | |

| | | | | | | | | |

| Investing activities: | | | | | | | | |

| Cash paid for acquisitions | | | (312 | ) | | | — | |

| Purchases of marketable securities, net | | | (34,818 | ) | | | (148 | ) |

| Purchase of other investments | | | (2,700 | ) | | | (1,500 | ) |

| Purchases of property and equipment | | | (1,980 | ) | | | (3,481 | ) |

| Payments associated with capitalized software development | | | (21,329 | ) | | | (21,910 | ) |

| Net cash used in investing activities | | | (61,139 | ) | | | (27,039 | ) |

| | | | | | | | | |

| Financing activities: | | | | | | | | |

| Taxes paid related to net settlement of equity awards | | | (786 | ) | | | (1,196 | ) |

| Payment of earn-outs related to acquisitions | | | (446 | ) | | | — | |

| Debt issuance costs | | | (301 | ) | | | — | |

| Payment of cash dividends | | | (3,071 | ) | | | (2,809 | ) |

| Proceeds from issuance of common stock | | | 39,882 | | | | — | |

| Repurchases of common stock | | | (9,306 | ) | | | (25,018 | ) |

| Net cash provided by (used in) financing activities | | | 25,972 | | | | (29,023 | ) |

| | | | | | | | | |

| Effect of exchange rate changes on cash and cash equivalents | | | 12 | | | | 10 | |

| Net increase (decrease) in cash and cash equivalents | | | 22,803 | | | | (5,925 | ) |

| Cash and cash equivalents at beginning of period | | | 36,161 | | | | 59,469 | |

| Cash and cash equivalents at end of period | | $ | 58,964 | | | $ | 53,544 | |

| Reconciliation of GAAP to Non-GAAP Financial Measures(1) Operating Results Summary (In thousands) (Unaudited) |

| | | Three Months Ended September 30**,** | | | Nine Months Ended September 30**,** | |

| | | 2026 | | | 2025 | | | 2026 | | | 2025 | |

| GAAP net income | | $ | 5,373 | | | $ | 6,086 | | | $ | 17,951 | | | $ | 15,808 | |

| Interest income | | | (510 | ) | | | (788 | ) | | | (1,399 | ) | | | (2,676 | ) |

| Interest expense | | | 26 | | | | 26 | | | | 76 | | | | 76 | |

| Income tax provision | | | 1,696 | | | | 2,166 | | | | 5,634 | | | | 4,559 | |

| Stock-based compensation expense | | | 1,196 | | | | 794 | | | | 3,611 | | | | 2,734 | |

| Depreciation and amortization | | | 11,265 | | | | 10,820 | | | | 33,905 | | | | 32,441 | |

| Fair value adjustment on contingent consideration | | | — | | | | — | | | | (4 | ) | | | — | |

| Cybersecurity incident costs | | | 250 | | | | — | | | | 250 | | | | — | |

| Adjusted EBITDA | | $ | 19,296 | | | $ | 19,104 | | | $ | 60,024 | | | $ | 52,942 | |

| (1) This press release presents adjusted EBITDA, which is a non-GAAP financial measure used by management in analyzing its financial results and ongoing operational performance. |

| Reconciliation of GAAP to Non-GAAP Financial Measures Financial Outlook for 2026 (In thousands) (Unaudited) |

| | | Low | | | High | |

| Net income | | $ | 21,800 | | | $ | 22,400 | |

| Interest income | | | (2,200 | ) | | | (2,400 | ) |

| Interest expense | | | 100 | | | | 100 | |

| Income tax provision | | | 6,900 | | | | 7,100 | |

| Stock-based compensation expense | | | 5,000 | | | | 5,200 | |

| Depreciation and amortization | | | 45,100 | | | | 45,300 | |

| Cybersecurity incident costs | | | 300 | | | | 300 | |

| Adjusted EBITDA | | $ | 77,000 | | | $ | 78,000 | |

This press release includes certain forward-looking statements (statements other than solely with respect to historical fact), including statements regarding expectations for financial performance for 2026 and our quarterly dividend that involve risks and uncertainties regarding HealthStream. These statements are based upon management’s beliefs, as well as assumptions made by and data currently available to management. This information has been, or in the future may be, included in reliance on the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. The Company cautions that forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results, performance, or achievements to be materially different from future results, performance, or achievements expressed or implied by the forward-looking statements, including as a result of negative economic conditions, changes in U.S. policy, adverse developments impacting the technology and healthcare industries, tariff and trade-related developments, inflationary pressures, geopolitical instability, and legal requirements and contractual restrictions which may affect the continuation of our quarterly cash dividend policy and the declaration and/or payment of dividends thereunder, which may be modified, suspended, or canceled in any manner and at any time that our Board may deem necessary or appropriate, as well as risks referenced in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, filed on February 26, 2026, and in the Company’s other filings with the Securities and Exchange Commission from time to time. Consequently, such forward-looking information should not be regarded as a representation or warranty or statement by the Company that such projections will be realized. Many of the factors that will determine the Company’s future results are beyond the ability of the Company to control or predict. Readers should not place undue reliance on forward-looking statements, which reflect management’s views only as of the date hereof. The Company undertakes no obligation to update or revise any such forward-looking statements.

View source version on businesswire.com: https://www.businesswire.com/news/home/20261102117319/en/

Scott A. Roberts Chief Financial Officer (615) 301-3182 [email protected]

Media: Mollie Condra, Ph.D. Head, Investor Relations & Communications (615) 301-3237 [email protected]

Source: HealthStream, Inc.

Search

Investors

Corporate Governance

Financial Information

Stock Information

Oct 26, 2026

Download PDF

NASHVILLE, Tenn.--(BUSINESS WIRE)--Oct. 26, 2026-- HealthStream, Inc. (Nasdaq: HSTM), a leading healthcare technology platform company for clinical workforce solutions, announced today that it will host a conference call and webcast to discuss its third quarter 2026 financial results on Tuesday, November 3, 2026. The Company’s financial results for the third quarter 2026, ended Sept. 30, 2026, will be released after the routine time for the close of the market on Monday, November 2, 2026.

HealthStream’s third quarter 2026 earnings conference call will begin at 9:00 a.m. Eastern Time on Tuesday, November 3, 2026. Participants may access the conference call live via webcast using this LINK. To participate via telephone, please register in advance using this LINK. Upon registration, all telephone participants will receive a one-time confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. All participants are instructed to dial-in 15 minutes prior to the start time. A replay of the conference call and webcast will be archived on the Company's website for at least 30 days.

About HealthStream

HealthStream (Nasdaq: HSTM) is the healthcare industry’s largest ecosystem of platform-delivered clinical workforce solutions that empowers healthcare professionals to do what they do best: deliver excellence in patient care. For more information, visit http://www.healthstream.com or call 615-301-3100.

This press release contains forward-looking statements that involve risks and uncertainties regarding HealthStream. This information has been included in reliance on the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such results or events predicted in these statements may differ materially from actual future events or results. These forward-looking statements are based on a variety of assumptions that may not be realized, and which are subject to significant risks and uncertainties, including that the anticipated financial and strategic benefits of the acquisition may not be realized, as well as risks and uncertainties referenced from time to time in the Company’s filings with the Securities and Exchange Commission.

View source version on businesswire.com: https://www.businesswire.com/news/home/20261026213910/en/

Mollie Condra, Ph.D. Head, Investor Relations & Corporate Communications HealthStream (615) 301-3237 [email protected]

Source: HealthStream, Inc.

Search

Investors

Corporate Governance

Financial Information

Stock Information

On September 18, 2026, the Compensation Committee (the “Committee”) of the Board of Directors of HealthStream, Inc. (the “Company”) approved special grants of time-based restricted share units (“Time-Based RSUs”) and performance-based restricted share units (“Performance-Based RSUs”) to the named executive officers of the Company pursuant to the Company’s shareholder-approved 2022 Omnibus Incentive Plan to incentivize future performance and retention, as described below.

The Committee approved the grant of (i) 15,395 Time-Based RSUs to each of Robert A. Frist, Jr., Michael M. Collier, Trisha L. Coady, and Kevin P. O’Hara (with a grant date fair value of $450,000 for each such named executive officer); and (ii) 12,316 Time-Based RSUs to Scott A. Roberts (with a grant date fair value of $360,000). These Time-Based RSUs will vest in equal annual installments of 25% on the first, second, third, and fourth anniversaries of the grant date.

The Committee also approved the grant of (i) 5,132 Performance-Based RSUs to each of Mr. Frist, Mr. Collier, Ms. Coady, and Mr.

Prompts

HealthStream, Inc. (ticker HSTM), listed in United States.

ETFs Holding HealthStream, Inc.

ETF Weight in ETF Shares Market value As of
FORH 2.69% 19,479 $ 530.803K Jun 30, 2026
SIXL 0.40% 29,308 $ 829.123K Nov 12, 2026
ESSC 0.32% 4,089 $ 114.656K Jul 31, 2026
SQLV 0.24% 2,570 $ 70.033K Jun 30, 2026
VFMV 0.19% 28,839 $ 837.773K Aug 31, 2026
IVSS 0.16% 1,605 $ 43.736K Jun 30, 2026
FESM 0.07% 138,170 $ 3.765M Jun 30, 2026
AVSC 0.05% 52,741 $ 1.46M Nov 16, 2026
PSC 0.05% 39,449 $ 1.075M Jun 30, 2026
DFAT 0.04% 487,269 $ 13.785M Nov 12, 2026
SYZ 0.04% 1,082 $ 29.485K Jun 30, 2026
DFSV 0.03% 322,284 $ 9.117M Nov 12, 2026
RESM 0.03% 40 $ 1,090.00 Jun 30, 2026
FEAC 0.02% 200 $ 5,450.00 Jun 30, 2026
DFAS 0.02% 247,064 $ 6.989M Nov 12, 2026
JMEE 0.02% 20,097 $ 555.28K Nov 17, 2026
DXUV 0.01% 12,360 $ 349.664K Nov 12, 2026
DFSU 0.00% 3,485 $ 98.591K Nov 12, 2026
MSSM 0.00% 990 $ 28.76K Aug 31, 2026
DFAC 0.00% 115,937 $ 3.28M Nov 12, 2026
DCOR 0.00% 30,754 $ 870.031K Nov 12, 2026
DFUV 0.00% 9,731 $ 275.29K Nov 12, 2026
DFAU 0.00% 7,447 $ 210.676K Nov 12, 2026
DFUS 0.00% 8,875 $ 251.074K Nov 12, 2026
EBI 0.00% 27 $ 784.35 Aug 31, 2026
AVUS 0.00% 3,987 $ 110.36K Nov 16, 2026